BioCentury | Aug 26, 2020
Deals

Aug. 25 Quick Takes: A slew of private financings led by Connect’s $115M series C; plus BMS-Forbius, Takeda deals, Bio-Thera-BeiGene and adds to HKSE, NASDAQ queues

...Equity, New Leaf Venture Partners, Novo Holdings, OrbiMed Advisors and Perceptive Advisors.Seed funding for Sirnaomics spinout RNAimmune Inc....
...Ltd. Bristol Myers Squibb Co. Forbius Takeda Pharmaceutical Co. Ltd. Blackstone Group Bio-Thera Solutions Ltd. BeiGene Ltd. Prelude Therapeutics Inc. Silence Therapeutics plc Sirnaomics Inc. RNAimmune Inc. Dyne...
BioCentury | Jun 12, 2020
Product Development

June 11 Quick Takes: Sobi licenses Selecta gout therapy; plus Viela’s first approval, CSL, BMS, Sirnaomics’ spinout, Denali-Sanofi

...Sirnaomics Inc. is spinning out its mRNA-based therapeutics and vaccines platform into an independent company, RNAimmune Inc....
Items per page:
1 - 2 of 2
BioCentury | Aug 26, 2020
Deals

Aug. 25 Quick Takes: A slew of private financings led by Connect’s $115M series C; plus BMS-Forbius, Takeda deals, Bio-Thera-BeiGene and adds to HKSE, NASDAQ queues

...Equity, New Leaf Venture Partners, Novo Holdings, OrbiMed Advisors and Perceptive Advisors.Seed funding for Sirnaomics spinout RNAimmune Inc....
...Ltd. Bristol Myers Squibb Co. Forbius Takeda Pharmaceutical Co. Ltd. Blackstone Group Bio-Thera Solutions Ltd. BeiGene Ltd. Prelude Therapeutics Inc. Silence Therapeutics plc Sirnaomics Inc. RNAimmune Inc. Dyne...
BioCentury | Jun 12, 2020
Product Development

June 11 Quick Takes: Sobi licenses Selecta gout therapy; plus Viela’s first approval, CSL, BMS, Sirnaomics’ spinout, Denali-Sanofi

...Sirnaomics Inc. is spinning out its mRNA-based therapeutics and vaccines platform into an independent company, RNAimmune Inc....
Items per page:
1 - 2 of 2